Image

Integrating the Youth Nominated Support Team (YST) With CBT for Black Youth With Acute Suicide Risk: Aim 2b

Integrating the Youth Nominated Support Team (YST) With CBT for Black Youth With Acute Suicide Risk: Aim 2b

Recruiting
12 years and older
All
Phase N/A

Powered by AI

Overview

This is a second pilot study being completed based on lessons learned from the Aim 2a feasibility pilot study (NCT06941311). Following modifications, the investigators are testing the acceptability, feasibility, and preliminary effectiveness of the combination of two psychosocial interventions, Cognitive Behavioral Therapy for Suicide Prevention (CBT-SP) and the computer-assisted version of the Youth-Nominated Support Team (eYST).

In this phase of the study, CBT-SP + eYST will be tested in an open trial (number of youth = 15). Investigators will recruit Black adolescents (ages 12-17) that come to an urban acute care setting for suicidal thoughts and/or self-injurious behaviors to receive the intervention in an outpatient community mental health agency. Participants will receive 12-14 sessions of CBT-SP in addition to YST. Participants will nominate up to 5 caring adults in their lives to serve as support persons. These support persons will attend an education/orientation session to learn more about their role and how to support the youth. Support persons will have weekly contact with the youth and weekly follow up contacts from the youth's clinician/YST intervention specialist.

Youth will be assessed at baseline, 6 weeks, and 14 weeks. Parents will be assessed at baseline and 14 weeks. Support persons will be assessed at baseline and 14 weeks.

Fidelity assessments will be completed by clinicians after each session, after the YST psycho-ed session, and weekly to document contact with the support team.

Eligibility

Youth Inclusion Criteria:

  • Patients that are able to provide at least one verifiable contact for emergency or tracking purposes
  • Willing to receive care at MiSide
  • Present to an acute emergency care setting with suicide risk (per protocol)
  • Self-identify as Black
  • Willing and able to complete enrollment procedures
  • Willing and able to provide signed and dated informed assent

Youth Exclusion Criteria:

  • Unable to be consented in English
  • Do not have a parent/legal guardian available to provide consent
  • Are not able to provide informed assent or to participate in the assessment due to significant agitation, psychosis, cognitive impairment, learning disability, or medical trauma
  • Actively engaged in specialty mental health treatment
  • Participated in the Aim 2a open trial

Parent/Guardian Inclusion Criteria:

  • Adults 18 years and older
  • The parent or legal guardian of a youth participating in this Aim
  • Understand written and spoken English
  • Willing and able to complete enrollment procedures
  • Willing and able to provide signed and dated informed consent
  • Need to have access to technology, either cell or an email address

Parent/Guardian Exclusion Criteria:

\- Do not understand written and spoken English

Support Person Inclusion Criteria:

  • Adults 18 years and older
  • Understand written and spoken English
  • Approved to serve as a support person by the parent/legal guardian

Support Person Exclusion Criteria:

  • Do not understand written and spoken English
  • Not approved to serve as a support person by the parent/guardian

Study details
    Suicide Prevention
    Suicide
    Self-Injurious Behavior
    Behavioral Symptoms
    Behavior

NCT07506460

University of Michigan

13 May 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.